Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $28.44, with a market capitalization of 162.13B. The stock trades at a price-to-earnings (P/E) ratio of 37.67 and offers a dividend yield of 6.05%.
On 2026-09-05, Pfizer(PFE) stock traded between a low of $28.38 and a high of $28.70. Shares are currently priced at $28.44, which is +0.2% above the low and -0.9% below the high.
The Pfizer(PFE)'s current trading volume is 23.79M, compared to an average daily volume of 32.74M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly reshaping its long‑term growt...
...
Key Points AbbVie leverages a strong pipeline in immunology and oncology to drive nearly $61.2 billion in annual revenue. Pfizer maintains a diverse portfolio...
Analyst ratings
66%
of 29 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a Phase 3 study in Japan called VESPER-JW to test once-wee...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed a Phase 1 study called “A PHASE 1, OPEN LABEL, SINGLE DOS...
Investing Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying? Pfizer shareholders are collecting a 6% yield while the stock bleeds value, a...
Pfizer stock has delivered a 25.6% return over the past year, yet the overall valuation checks point to a mixed picture rather than a clear bargain or clear pre...
Medicus Pharma Ltd. (NASDAQ:MDCX) secured on Wednesday an exclusive, sublicensable global license from Pfizer Inc. (NYSE:PFE) to develop, manufacture, and comme...
Pfizer’s PFE R&D pipeline is becoming an increasingly important part of the investment story as the company is trying to revive growth after the sharp decline i...
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the October 23rd expiration. At Stock Options Channel, our YieldBoost formula...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.